Potential theranostic approach of 177Lu-trastuzumab and 177Lu-FAPI in metastatic breast cancer: An ongoing study

被引：0
|
作者：
Assadi, M. [1 ]
Rekabpour, S. [1 ]
Jokar, N. [1 ]
Ahmadzadehfar, H. [2 ]
Jafari, E. [1 ]
机构：
[1] Bushehr Univ Med Sci BUMS, Bushehr, Iran
[2] Klinikum Westfalen, Dept Nucl Med, Dortmund, Germany
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2021年 / 48卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-0815
引用
收藏
页码：S291 / S291
页数：1
相关论文
共 50 条
  • [1] Preparation of 177Lu-Trastuzumab injection for treatment of breast cancer
    Kameswaran, Mythili
    Pandey, Usha
    Gamre, Naresh
    Sarma, Haladhar Dev
    Dash, Ashutosh
    APPLIED RADIATION AND ISOTOPES, 2019, 148 : 184 - 190
  • [2] 177Lu-FAPI Therapy in a Patient With End-Stage Metastatic Pancreatic Adenocarcinoma
    Kaghazchi, Fatemeh
    Aghdam, Ramin Akbarian
    Haghighi, Shirin
    Vali, Reza
    Adinehpour, Zohreh
    CLINICAL NUCLEAR MEDICINE, 2022, 47 (03) : E243 - E245
  • [3] Synthesis and biodistribution studies of 177Lu-trastuzumab as a therapeutic agent in the breast cancer mice model
    Rasaneh, Samira
    Rajabi, Hossein
    Babaei, Mohammad Hossein
    Daha, Fariba Johari
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2010, 53 (09): : 575 - 579
  • [4] Formulation and clinical translation of [177Lu]Lu-trastuzumab for radioimmunotheranostics of metastatic breast cancer
    Guleria, Mohini
    Sharma, Rohit
    Amirdhanayagam, Jeyachitra
    Sarma, Haladhar D.
    Rangarajan, Venkatesh
    Dash, Ashutosh
    Das, Tapas
    RSC MEDICINAL CHEMISTRY, 2021, 12 (02): : 263 - 277
  • [5] Assessment of theranostic potential of Lu-177-trastuzumab in HER2 expressing breast cancer patients
    Shukla, J.
    Bhusari, P.
    Vatsa, R.
    Singh, G.
    Bal, A.
    Parmar, M.
    Dhawan, D. K.
    Mittal, B. R.
    EUROPEAN JOURNAL OF CANCER, 2016, 54 : S28 - S28
  • [6] Feasibility and therapeutic potential of [177Lu]Lu-FAPI-2286 in patients with advanced metastatic sarcoma
    Banihashemian, Seyedeh Somayyeh
    Akbari, Mohammad Esmaeil
    Pirayesh, Elahe
    Divband, Ghasemali
    Shahrnoy, Abdolghafar Abolhosseini
    Nami, Reza
    Mazidi, Seyed Mohammad
    Nasiri, Meysam
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 52 (01) : 237 - 246
  • [7] Therapeutic potential of [177Lu]Lu-DOTAGA-FAPi dimers in metastatic breast cancer patients with limited treatment options: efficacy and safety assessment
    Madhav P. Yadav
    Sanjana Ballal
    Marcel Martin
    Frank Roesch
    Swayamjeet Satapathy
    Euy S. Moon
    Madhavi Tripathi
    Ajay Gogia
    Chandrasekhar Bal
    European Journal of Nuclear Medicine and Molecular Imaging, 2024, 51 : 805 - 819
  • [8] Therapeutic potential of [177Lu]Lu-DOTAGA-FAPi dimers in metastatic breast cancer patients with limited treatment options: efficacy and safety assessment
    Yadav, Madhav P.
    Ballal, Sanjana
    Martin, Marcel
    Roesch, Frank
    Satapathy, Swayamjeet
    Moon, Euy S.
    Tripathi, Madhavi
    Gogia, Ajay
    Bal, Chandrasekhar
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 (03) : 805 - 819
  • [9] Theranostic Treatment of Metastatic Bone Pain With 177Lu-DOTMP
    Das, Tapas
    Shinto, Ajit
    Kamaleshwaran, Koramadai Karuppuswamy
    Banerjee, Sharmila
    CLINICAL NUCLEAR MEDICINE, 2016, 41 (12) : 966 - 967
  • [10] Analysis of absorbed dose in radioimmunotherapy with 177Lu-trastuzumab using two different imaging scenarios: a pilot study
    Nautiyal, Amit
    Jha, Ashish K.
    Mithun, Sneha
    Shetye, Bhakti
    Kameswaran, Mythili
    Shah, Sneha
    Rangarajan, Venkatesh
    Gupta, Sudeep
    NUCLEAR MEDICINE COMMUNICATIONS, 2021, 42 (12) : 1382 - 1395
12345